European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties Joint - Virtual meeting

• Date:
  Tuesday, 2 June 2020, All day
• Location:
  Online
  European Medicines Agency, Amsterdam, the Netherlands

This half-day joint virtual meeting will focus on:

• EMA's response to COVID-19;
• availability of medicines (medicine shortages);
• data protection (including a questions-and-answers session on secondary use of health data).

In addition to working-party-member organisations, all EMA eligible organisations are invited to participate in this meeting.

Documents

Meeting summary - PCWP/HCPWP joint meeting on 2 June 2020

Reference Number: EMA/313148/2020

Agenda - European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties Joint - Virtual meeting

Reference Number: EMA/147856/2020

Presentation - 1.1 Agency’s contribution to the pandemic response (N. Wathion)

Presentation - 1.2 COVID-19 pandemic: update (M. Cavaleri)

Presentation - 1.3.1 Clinical Trials and COVID-19 (F. Sweeney)

Presentation - 1.3.2 COVID 19: EMA activities in relation to observational studies on use of medicines (X. Kurz)

Presentation - 1.4 Securing availability of medicines across the EU (M. Dias)

Presentation - 1.5 Providing public health advice and communicating during a crisis (M. Carr, M-A. Heine)

Presentation - 2.1 HMA/EMA Task Force on Availability of Authorised Medicines: update on progress (K. Raudsepp)

Presentation - 2.2 PCWP/HCPWP input to the HMA/EMA concept paper on best practices to prevent shortages (P. Kolczynski)

Presentation - 3.1 Electronic Health Record: Access, Share, Expand project (S. Brosch)

Presentation - 3.2 Electronic Health Record: Access, Share, Expand project: Secondary use of healthcare data; groundwork for Q&A (O. Eotvos)

Presentation - 3.3 Electronic Health Record: Access, Share, Expand project: Overview of stakeholder feedback received (S. Brosch)

Video recordings